Stay updated on Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown, replacing Revision: v3.3.1. No changes to study details, eligibility criteria, or listed locations were observed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:33:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The Publications section description was updated to state that publications are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:38:48.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page removed a generic government funding/operating status notice; this does not affect the study content, design, eligibility criteria, outcomes, or contacts on the ClinicalTrials.gov record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:17:20.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT03661138; the page content appears unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T00:52:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Page now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T07:51:40.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.
    Difference
    0.4%
    Check dated 2025-09-28T02:59:00.000Z thumbnail image

Stay in the know with updates to Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.